Business
Here’s why the Mayne Pharma (ASX:MYX) share price is shooting 28% higher
The Mayne Pharma Group Ltd (ASX: MYX) share price is shooting higher on Friday morning.
At the time of writing, the pharmaceutical company’s shares are up a massive 28% to 59 cents.
This latest gain means the Mayne Pharma share price is now up 69% since the start of the year.
Why is the Mayne Pharma share price charging higher?
Investors have been buying the company’s shares this morning following the release of a very positive announcement.
According to the release, the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) from Mayne Pharma and Mithra Pharmaceuticals for the novel combined oral contraceptive Nextstellis.
Following this approval, Mayne Pharma anticipates the commercial launch of…
-
Noosa News20 hours agoLuxury caravan manufacturer Zone RV collapses into administration
-
General21 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
General8 hours agoBoard stacking allegations as RACP directors call snap meeting
-
General20 hours agoCase against teens charged over Adelaide shopping centre stabbing could move to adult court